Login / Signup

Efficacy and immune-related adverse event associations in avelumab-treated patients.

Karen KellyJuliane ManitzManish R PatelSandra P D' AngeloAndrea B ApoloArun RajanVijay KasturiIsabell SpeitMarcis BajarsJohn WarthJames L Gulley
Published in: Journal for immunotherapy of cancer (2021)
NCT01772004 and NCT02155647.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • emergency department
  • patient reported